<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39450880</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0274</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>American journal of industrial medicine</Title><ISOAbbreviation>Am J Ind Med</ISOAbbreviation></Journal><ArticleTitle>Functional disabilities and adverse well-being by COVID-19 and Long COVID history and employment status: 2022 Behavioral Risk Factor Surveillance System.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajim.23669</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID can lead to functional disabilities and decreased well-being and limit the ability to work. No study has yet assessed associations of SARS-CoV-2-infection and Long COVID with specific measures of well-being and functional disabilities among workers by employment status.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using data from the U.S. Behavioral Risk Factor Surveillance System, we assessed the prevalence of functional disabilities and well-being measures among adults of prime working age (25-54 years) by employment status and self-reported COVID-19 and Long COVID history. Within each employment status, we generated adjusted prevalence ratios (aPRs) comparing respondents from each 2022 COVID-19/Long COVID category to respondents in that employment status before the pandemic (2019).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2022, prevalences of each functional disability except vision and all adverse well-being measures were highest among the 9.2% of respondents reporting a history of Long COVID. For each outcome, prevalences were lowest for workers and highest among those unable to work. 2022 prevalence of cognitive disability (16.4% of employees, 21.4% of the self-employed) and depression (31.2% and 36.4%, respectively) among workers reporting a history of Long COVID were more than double 2019 levels. Increases in cognitive disability and depression were lower but statistically significant among workers not reporting a history of Long COVID.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The high prevalence of functional disabilities and adverse well-being among workers reporting a history of Long COVID have implications for workers and employers. Also concerning are smaller increases among workers not reporting a history of Long COVID, given the large number of affected workers. Mitigating the effects of Long COVID on workers will involve efforts in multiple domains: reducing incidence, increasing healthcare practitioner awareness, improving diagnosis and treatments, and increasing employer awareness of best practices for accommodating workers with Long COVID.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silver</LastName><ForeName>Sharon R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0002-7679-5028</Identifier><AffiliationInfo><Affiliation>Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jia</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0692-5103</Identifier><AffiliationInfo><Affiliation>Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Nicole D</ForeName><Initials>ND</Initials><Identifier Source="ORCID">0000-0002-6463-5094</Identifier><AffiliationInfo><Affiliation>Coronaviruses and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-6350-5300</Identifier><AffiliationInfo><Affiliation>Coronaviruses and Other Respiratory Viruses Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ind Med</MedlineTA><NlmUniqueID>8101110</NlmUniqueID><ISSNLinking>0271-3586</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">employment status</Keyword><Keyword MajorTopicYN="N">functional disability</Keyword><Keyword MajorTopicYN="N">well‐being</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39450880</ArticleId><ArticleId IdType="doi">10.1002/ajim.23669</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Parotto M, Gyöngyösi M, Howe K, et al. Post‐acute sequelae of COVID‐19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023;11(8):739‐754. doi:10.1016/S2213-2600(23)00239-4</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133‐146. doi:10.1038/s41579-022-00846-2</Citation></Reference><Reference><Citation>Sheiner L, Salwati N How much is long COVID reducing labor force participation? Not much (so far). Vol. 80. 2022. Hutchins Center Working Paper. Accessed 01/15/2024. https://www.brookings.edu/wp-content/uploads/2022/10/WP80-Sheiner-Salwati_10.27.pdf</Citation></Reference><Reference><Citation>Tak CR. The health impact of long COVID: a cross‐sectional examination of health‐related quality of life, disability, and health status among individuals with self‐reported post‐acute sequelae of SARS CoV‐2 infection at various points of recovery. J Patient‐Reported Outcomes. 2023;7(1):31. doi:10.1186/s41687-023-00572-0</Citation></Reference><Reference><Citation>Vélez‐Santamaría R, Fernández‐Solana J, Méndez‐López F, et al. Functionality, physical activity, fatigue and quality of life in patients with acute COVID‐19 and long COVID infection. Sci Rep. 2023;13(1):19907. doi:10.1038/s41598-023-47218-1</Citation></Reference><Reference><Citation>Bach K New data shows long Covid is keeping as many as 4 million people out of work. 2022. Accessed 01/15/2024. https://www.brookings.edu/articles/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work/#:~:text=This%20report%20uses%20the%20new,work%20due%20to%20long%20Covid.</Citation></Reference><Reference><Citation>Green CE, Leeds JS, Leeds CM. Occupational effects in patients with post‐COVID‐19 syndrome. Occup Med. 2023;74(1):86‐92. doi:10.1093/occmed/kqad118</Citation></Reference><Reference><Citation>Ham DI. Long‐haulers and labor market outcomes. Vol. 60 2022; Working Papers https://www.minneapolisfed.org/research/institute-working-papers/long-haulers-and-labor-market-outcomes.</Citation></Reference><Reference><Citation>Kwon J, Milne R, Rayner C, et al Impact of long COVID on productivity and informal caregiving. Eur J Health Econ. 2023;25:1019‐1115. doi:10.1007/s10198-023-01653-z</Citation></Reference><Reference><Citation>Nielsen K, Yarker J. “It's a rollercoaster”: the recovery and return to work experiences of workers with long COVID. Work Stress. 2023;38(2):202‐230. doi:10.1080/02678373.2023.2286654</Citation></Reference><Reference><Citation>Lunt J, Hemming S, Elander J, Baraniak A, Burton K, Ellington D. Experiences of workers with post‐COVID‐19 symptoms can signpost suitable workplace accommodations. Int J Workplace Health Manag. 2022;15(3):359‐374. doi:10.1108/IJWHM-03-2021-0075</Citation></Reference><Reference><Citation>Gallegos M, Morgan ML, Burgos‐Videla C, Caycho‐Rodríguez T, Martino P, Cervigni M. The impact of long covid on people's capacity to work. Ann Work Expo Health. 2023;67(7):801‐804. doi:10.1093/annweh/wxad029</Citation></Reference><Reference><Citation>Kerksieck P, Ballouz T, Haile SR, et al. Post COVID‐19 condition, work ability and occupational changes in a population‐based cohort. Lancet Region Health Eur. 2023;31(23):100671. doi:10.1016/j.lanepe.2023.100671</Citation></Reference><Reference><Citation>Lemhöfer C, Sturm C, Loudovici‐Krug D, et al. Quality of life and ability to work of patients with Post‐COVID syndrome in relation to the number of existing symptoms and the duration since infection up to 12 months: a cross‐sectional study. Qual Life Res. 2023;32(7):1991‐2002. doi:10.1007/s11136-023-03369-2</Citation></Reference><Reference><Citation>Hair NL, Urban C. Association of severe COVID‐19 and persistent COVID‐19 symptoms with economic hardship among US families. JAMA Network Open. 2023;6(12):e2347318‐e2347318. doi:10.1001/jamanetworkopen.2023.47318</Citation></Reference><Reference><Citation>Ne'eman A, Maestas N. How has COVID‐19 impacted disability employment? Disabil Health J. 2023;16(2):101429. doi:10.1016/j.dhjo.2022.101429</Citation></Reference><Reference><Citation>U.S. Bureau of Labor Statistics. Civilian labor force participation rate by age,sex, race, and ethnicity. Table 3.3. 2002, 2012, 2022, and projected 2032. Accessed 04/05/2024. https://www.bls.gov/emp/tables/civilian-labor-force-participation-rate.htm</Citation></Reference><Reference><Citation>Bonner C, Ghouralal S‐L. Long COVID and chronic conditions in the US workforce: prevalence, productivity loss, and disability. J Occup Environ Med. 2024;66(3):e80‐e86. doi:10.1097/JOM.0000000000003026</Citation></Reference><Reference><Citation>Jeffrey K, Woolford L, Maini R, et al. Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study. eClinicalMedicine. 2024;71:102590. doi:10.1016/j.eclinm.2024.102590</Citation></Reference><Reference><Citation>Bell JA, Sabia S, Singh‐Manoux A, Hamer M, Kivimäki M. Healthy obesity and risk of accelerated functional decline and disability. Int J Obes. 2017;41(6):866‐872. doi:10.1038/ijo.2017.51</Citation></Reference><Reference><Citation>Sirtori A, Brunani A, Villa V, et al. Obesity is a marker of reduction in QoL and disability. Sci World J. 2012;2012:167520. https://onlinelibrary.wiley.com/action/showCitFormats?doi=10.1100%2F2012%2F167520</Citation></Reference><Reference><Citation>Ul‐Haq Z, Mackay DF, Fenwick E, Pell JP. Meta‐analysis of the association between body mass index and health‐related quality of life among adults, assessed by the SF‐36. Obesity. 2013;21(3):E322‐E327. doi:10.1002/oby.20107</Citation></Reference><Reference><Citation>Graubard BI, Korn EL. Predictive margins with survey data. Biometrics. 1999;55:652‐659.</Citation></Reference><Reference><Citation>Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702‐706. doi:10.1093/aje/kwh090</Citation></Reference><Reference><Citation>Silver SR, Li J, Quay B. Employment status, unemployment duration, and health‐related metrics among US adults of prime working age: behavioral risk factor surveillance system, 2018‐2019. Am J Ind Med. 2022;65(1):59‐71. doi:10.1002/ajim.23308</Citation></Reference><Reference><Citation>Karpman M, Zuckerman S, Morriss S. Health care access and affordability among US adults aged 18 to 64 years with self‐reported Post–COVID‐19 condition. JAMA Network Open. 2023;6(4):e237455. doi:10.1001/jamanetworkopen.2023.7455</Citation></Reference><Reference><Citation>Karpman M, Fiol O, Popkin SJ, McCorkell L, Waxman E, Morriss S Employment and material hardship among adults with long COVID in December 2022. 2023. July 2023. https://www.urban.org/research/publication/employment-and-material-hardship-among-adults-long-covid-december-2022</Citation></Reference><Reference><Citation>Feldstein LR, Edwards D, Cope JR, Hagen MB, Saydah S. Differences in report of Post‐COVID conditions among adults tested for SARS‐CoV‐2 by race and ethnicity: 2022 porter novelli SummerStyles survey, U.S. AJPM Focus. 2024;3(2):100181. doi:10.1016/j.focus.2023.100181</Citation></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Network Open. 2022;5(10):e2238804. doi:10.1001/jamanetworkopen.2022.38804</Citation></Reference><Reference><Citation>Perlis RH, Trujillo KL, Safarpour A, et al. Research Letter: Association between long COVID symptoms and employment status. medRxiv. 2022. doi:10.1101/2022.11.17.22282452</Citation></Reference><Reference><Citation>Miskowiak KW, Pedersen JK, Gunnarsson DV, et al. Cognitive impairments among patients in a long‐COVID clinic: prevalence, pattern and relation to illness severity, work function and quality of life. J Affect Disord. 2023;324:162‐169. doi:10.1016/j.jad.2022.12.122</Citation></Reference><Reference><Citation>Zhao S, Martin EM, Reuken PA, et al. Long COVID is associated with severe cognitive slowing: a multicentre cross‐sectional study. eClinicalMedicine. 2024;68:102434. doi:10.1016/j.eclinm.2024.102434</Citation></Reference><Reference><Citation>Substance Abuse and Mental Health Services Administration (SAMHSA). A Preliminary Look at the Mental Health and Substance Use‐related Effects of the COVID‐19 Pandemic (2021). Accessed 05/24/24. https://www.samhsa.gov/sites/default/files/dtac/mental-health-substance-use-effects-covid-pandemic-srb.pdf</Citation></Reference><Reference><Citation>Blanchflower DG, Bryson A. Long COVID in the United States. PLoS One. 2023;18(11):e0292672. doi:10.1371/journal.pone.0292672</Citation></Reference><Reference><Citation>Drieskens S, Demarest S, Bel S, De Ridder K, Tafforeau J. Correction of self‐reported BMI based on objective measurements: a Belgian experience. Arch Public Health. 2018;76:10. doi:10.1186/s13690-018-0255-7</Citation></Reference><Reference><Citation>Connor Gorber S, Shields M, Tremblay MS, McDowell I. The feasibility of establishing correction factors to adjust self‐reported estimates of obesity. Health Rep. 2008;19(3):71‐82.</Citation></Reference><Reference><Citation>Hayes AJ, Kortt MA, Clarke PM, Brandrup JD. Estimating equations to correct self‐reported height and weight: implications for prevalence of overweight and obesity in Australia. Aust N Z J Public Health. 2008;32(6):542‐545. doi:10.1111/j.1753-6405.2008.00306.x</Citation></Reference><Reference><Citation>Scholes S, Ng Fat L, Moody A, Mindell JS. Does the use of prediction equations to correct self‐reported height and weight improve obesity prevalence estimates? A pooled cross‐sectional analysis of health survey for england data. BMJ Open. 2023;13(1):e061809. doi:10.1136/bmjopen-2022-061809</Citation></Reference><Reference><Citation>Keramat SA, Alam K, Rana RH, et al. Obesity and the risk of developing chronic diseases in middle‐aged and older adults: findings from an Australian longitudinal population survey, 2009‐2017. PLoS ONE. 2021;16(11):e0260158. doi:10.1371/journal.pone.0260158</Citation></Reference><Reference><Citation>Ballouz T, Menges D, Anagnostopoulos A, et al. Recovery and symptom trajectories up to two years after SARS‐CoV‐2 infection: population based, longitudinal cohort study. BMJ. 2023;381:e074425. doi:10.1136/bmj-2022-074425</Citation></Reference><Reference><Citation>Agergaard J, Gunst JD, Schiøttz‐Christensen B, Østergaard L, Wejse C. Long‐term prognosis at 1.5 years after infection with wild‐type strain of SARS‐CoV‐2 and alpha, delta, as well as omicron variants. Int J Infect Dis. 2023;137:126‐133. doi:10.1016/j.ijid.2023.10.022</Citation></Reference><Reference><Citation>Montoy JCC, Ford J, Yu H, et al. Prevalence of symptoms ≤12 months after acute illness, by COVID‐19 testing status among adults ‐ United States, December 2020‐March 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):859‐865. doi:10.15585/mmwr.mm7232a2</Citation></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, et al. Long COVID and significant activity limitation among adults, by age ‐ United States, June 1‐13, 2022, to June 7‐19, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):866‐870. doi:10.15585/mmwr.mm7232a3</Citation></Reference><Reference><Citation>Martínez‐Pozas O, Meléndez‐Oliva E, Rolando LM. et. al. the pulmonary rehabilitation effect on long covid‐19 syndrome: A systematic review and meta‐analysis. Physiother Res Int. 2024;29(2):e2077. doi:10.1002/pri.2077</Citation></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. 2023;108:12‐27. doi:10.1113/EP090802</Citation></Reference><Reference><Citation>Bland AR, Barraclough M, Trender WR, et al. Profiles of objective and subjective cognitive function in Post‐COVID syndrome, COVID‐19 recovered, and COVID‐19 naïve individuals. Sci Rep. 2024;14(1):13368. doi:10.1038/s41598-024-62050-x.</Citation></Reference><Reference><Citation>American Academy of Physical Medicine and Rehabilitation. Multidisciplinary Quality Improvement Initiative: Published Guidance. https://www.aapmr.org/advocacy/current-priorities/long-covid-pasc/multidisciplinary-quality-improvement-initiative?utm_source=google&amp;utm_medium=organic&amp;utm_campaign=AAPMR Accessed 08/20/2024.</Citation></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, et al. The Post‐COVID‐19 functional status scale: a tool to measure functional status over time after COVID‐19. Eur Respir J. 2020;56(1):2001494. doi:10.1183/13993003.01494-2020</Citation></Reference><Reference><Citation>Fancourt D, Steptoe A, Bu F. Psychological consequences of long COVID: comparing trajectories of depressive and anxiety symptoms before and after contracting SARS‐CoV‐2 between matched long‐ and short‐COVID groups. Br J Psychiatry. 2023;222(2):74‐81. doi:10.1192/bjp.2022.155</Citation></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra‐brief screening scale for anxiety and depression: the PHQ‐4. Psychosomatics. 2009;50(6):613‐621. doi:10.1097/PSY.0000000000000322</Citation></Reference><Reference><Citation>Jones JM, Manrique IM, Stone MS, et al. Estimates of SARS‐CoV‐2 seroprevalence and incidence of primary SARS‐CoV‐2 infections among blood donors, by COVID‐19 vaccination status ‐ United States, April 2021‐September 2022. MMWR Morb Mortal Wkly Rep. 2023;72(22):601‐605. doi:10.15585/mmwr.mm7222a3</Citation></Reference><Reference><Citation>Lundberg‐Morris L, Leach S, Xu Y, et al. Covid‐19 vaccine effectiveness against post‐covid‐19 condition among 589 722 individuals in Sweden: population based cohort study. BMJ. 2023;383:e076990. doi:10.1136/bmj-2023-076990</Citation></Reference><Reference><Citation>Xie Z, Stallings‐Smith S, Patel S, Case S, Hong Y‐R. COVID‐19 booster vaccine uptake and reduced risks for long‐COVID: A cross‐sectional study of a U.S. adult population. Vaccine. 2024;42(16):3529‐3535. doi:10.1016/j.vaccine.2024.04.070</Citation></Reference><Reference><Citation>Yang C, Zhao H, Shannon CP, Tebbutt SJ. Omicron variants of SARS‐CoV‐2 and long COVID. Front Immunol. 2022;13:1061686. doi:10.3389/fimmu.2022.1061686</Citation></Reference><Reference><Citation>Boufidou F, Medić S, Lampropoulou V, Siafakas N, Tsakris A, Anastassopoulou C. SARS‐CoV‐2 reinfections and long COVID in the Post‐Omicron phase of the pandemic. Int J Mol Sci. 2023;24(16):12962. doi:10.3390/ijms241612962</Citation></Reference><Reference><Citation>Greenhalgh T, MacIntyre CR, Baker MG, et al. Masks and respirators for prevention of respiratory infections: a state of the science review. Clin Microbiol Rev. 2024;37:e00124‐23. doi:10.1128/cmr.00124-23</Citation></Reference><Reference><Citation>Izadyar N, Miller W. Ventilation strategies and design impacts on indoor airborne transmission: A review. Building Environ. 2022;218:109158. doi:10.1016/j.buildenv.2022.109158</Citation></Reference><Reference><Citation>Edwards CH, Tomba GS, de Blasio BF. Influenza in workplaces: transmission, workers’ adherence to sick leave advice and European sick leave recommendations. Eur J Public Health. 2016;26(3):478‐485. doi:10.1093/eurpub/ckw031</Citation></Reference><Reference><Citation>Packard SE, Susser E. Association of long COVID with housing insecurity in the United States, 2022–2023. SSM ‐ Population Health. 2024;25:101586. doi:10.1016/j.ssmph.2023.101586</Citation></Reference><Reference><Citation>Ford ND, Slaughter D, Dalton AF, et al. Health insurance and access to care in U.S. working age adults experiencing long COVID. Am J Prev Med. 2024;67:530‐539. doi:10.1016/j.amepre.2024.05.007</Citation></Reference><Reference><Citation>Li J, Li Y, Wang Z, Liu N, He L, Zhang H. Increased risk of new‐onset diabetes in patients with COVID‐19: a systematic review and meta‐analysis. Front Public Health. 2023;11:1170156. doi:10.3389/fpubh.2023.1170156</Citation></Reference><Reference><Citation>Gollop C, Zingel R, Jacob L, Smith L, Koyanagi A, Kostev K. Incidence of newly‐diagnosed dementia after COVID‐19 infection versus acute upper respiratory infection: A retrospective cohort study. J Alzheimer's Dis. 2023;93:1033‐1040. doi:10.3233/JAD-221271</Citation></Reference><Reference><Citation>Koyama AK, Imperatore G, Rolka DB, et al. Risk of cardiovascular disease after COVID‐19 diagnosis among adults with and without diabetes. J Am Heart Assoc. 2023;12(13):e029696. doi:10.1161/jaha.123.029696</Citation></Reference><Reference><Citation>Marjenberg Z, Leng S, Tascini C, et al. Risk of long COVID main symptoms after SARS‐CoV‐2 infection: a systematic review and meta‐analysis. Sci Rep. 2023;13(1):15332. doi:10.1038/s41598-023-42321-9</Citation></Reference><Reference><Citation>Sanchez Jimenez B, Sterling T, Brown A, et al. Wastewater surveillance in the COVID‐19 post‐emergency pandemic period: A promising approach to monitor and predict SARS‐CoV‐2 surges and evolution. Heliyon. 2023;9(11):e22356. doi:10.1016/j.heliyon.2023.e22356</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>